Literature DB >> 18314169

Removal of transobturator midurethral sling for refractory thigh pain.

Christopher E Wolter1, Jonathan S Starkman, Harriette M Scarpero, Roger R Dmochowski.   

Abstract

Polypropylene midurethral slings have become the most common surgical procedure for the treatment of stress urinary incontinence. The efficacy has been well established through prospective and systematic evaluation. Transobturator midurethral slings have demonstrated comparable efficacy relative to the retropubic approach with the potential to minimize the morbidity associated with retropubic needle passage. We present a case of recalcitrant medial thigh pain after transobturator midurethral sling placement that ultimately required medial thigh/transobturator exploration and sling excision.

Entities:  

Mesh:

Year:  2008        PMID: 18314169     DOI: 10.1016/j.urology.2007.12.052

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  Pre-ramus passage of inside-out transobturator sling.

Authors:  Ted M Roth
Journal:  Int Urogynecol J       Date:  2010-10-13       Impact factor: 2.894

2.  Characterization of pain after inside-out transobturator midurethral sling.

Authors:  Lauren A Cadish; Michele R Hacker; Anna Merport Modest; Kathleen J Rogers; Sybil Dessie; Eman A Elkadry
Journal:  Female Pelvic Med Reconstr Surg       Date:  2014 Mar-Apr       Impact factor: 2.091

Review 3.  Pain after suburethral sling insertion for urinary stress incontinence.

Authors:  Jonathan Duckett; Andrew Baranowski
Journal:  Int Urogynecol J       Date:  2012-07-03       Impact factor: 2.894

Review 4.  Surgical management of female SUI: is there a gold standard?

Authors:  Ashley Cox; Sender Herschorn; Livia Lee
Journal:  Nat Rev Urol       Date:  2013-01-15       Impact factor: 14.432

Review 5.  Update on complications of synthetic suburethral slings.

Authors:  Cristiano Mendes Gomes; Fabrício Leite Carvalho; Carlos Henrique Suzuki Bellucci; Thiago Souto Hemerly; Fábio Baracat; Jose de Bessa; Miguel Srougi; Homero Bruschini
Journal:  Int Braz J Urol       Date:  2017 Sep-Oct       Impact factor: 1.541

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.